Lupin: Glad To Have Dodged Humira Bullet, Lucentis Biosimilar Closer As Phase III Trials Succeed

Amazon, Mark Cuban Not Upset US Market Dynamics

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.